Winton Group’s Guardant Health GH Stock Holding History

Winton Group’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.57M	Buy	+17,130	New	+$1.86M	0.08%	253
2023 Q1	–	Sell	-9,724	Closed	-$264K	–	1004
2022 Q4	$264K	Buy	9,724 +4,823	+98%	+$221K	0.02%	810
2022 Q3	$264K	Buy	+4,901	New	+$252K	0.02%	829
2021 Q4	–	Sell	-3,907	Closed	-$488K	–	1152
2021 Q3	$488K	Buy	+3,907	New	+$464K	0.03%	874
2021 Q2	–	Sell	-6,633	Closed	-$1.01M	–	1456
2021 Q1	$1.01M	Sell	6,633 -15	-0.2%	-$2.27K	0.06%	454
2020 Q4	$857K	Sell	6,648 -27,096	-80%	-$3.12M	0.06%	489
2020 Q3	$3.77M	Sell	33,744 -32,082	-49%	-$2.93M	0.12%	228
2020 Q2	$5.34M	Buy	65,826 +54,356	+474%	+$4.38M	0.14%	188
2020 Q1	$798K	Buy	+11,470	New	+$880K	0.02%	881

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Winton Group's GH Position: Q2 2026 in Review

Winton Group opened a new position in Guardant Health (GH) in Q2 2026: 17,130 shares worth $2.57M. The stake represents 0.08% of the portfolio and ranks #253 among its holdings. This is a return to the name: Winton Group previously reported a position in GH as recently as Q4 2022.

Winton Group first reported a position in GH in Q1 2020 and has held it in 9 quarters since. The position peaked at $5.34M in Q2 2020. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Winton Group held 17,130 shares of Guardant Health worth $2.57M as of Q2 2026.
Guardant Health was a new Winton Group position in Q2 2026.
Guardant Health made up 0.08% of Winton Group's portfolio in Q2 2026, its #253 holding.
Winton Group first reported a position in Guardant Health in Q1 2020 and has held it in 9 quarters since.
Winton Group's Guardant Health position peaked at $5.34M in Q2 2020.
601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.